These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 21130395)

  • 21. Cytoreductive nephrectomy for metastatic renal cell carcinoma.
    McKiernan J; Wood CG
    J Urol; 2013 Aug; 190(2):386-8. PubMed ID: 23702308
    [No Abstract]   [Full Text] [Related]  

  • 22. [What is the importance of kidney cancer surgery in contrast with targeted therapies?].
    Ploussard G; de La Taille A
    Bull Cancer; 2010; 97():91-6. PubMed ID: 20418208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a role for presurgical therapy for renal cell carcinoma?
    Calabrò F; Sternberg CN
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):807-12. PubMed ID: 20553206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel targeted therapy for advanced renal carcinoma: trials in progress.
    Calabrò F; Sternberg CN
    Curr Opin Urol; 2010 Sep; 20(5):382-7. PubMed ID: 20625300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Finelli A; Kaouk JH; Fergany AF; Abreu SC; Novick AC; Gill IS
    BJU Int; 2004 Aug; 94(3):291-4. PubMed ID: 15291853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy.
    Russo P
    Nat Clin Pract Urol; 2004 Nov; 1(1):26-30. PubMed ID: 16474463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of surgery and systemic therapy in the management of metastatic renal cancer.
    Thomas AA; Rini BI; Campbell SC
    Curr Urol Rep; 2009 Jan; 10(1):35-41. PubMed ID: 19116094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Harshman LC; Srinivas S
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic renal cell carcinoma: recent advances in the targeted therapy era.
    Di Lorenzo G; Autorino R; Sternberg CN
    Eur Urol; 2009 Dec; 56(6):959-71. PubMed ID: 19748725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
    Franklin JR; Figlin R; Rauch J; Gitlitz B; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):230-6. PubMed ID: 8946623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Capitanio et al.: Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. (Urology 2008;72:1090-1095).
    Chung SD; Chu SH; Tsai CC
    Urology; 2009 Mar; 73(3):682-3; author reply 683-4. PubMed ID: 19248907
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.
    Russo P; O'Brien MF
    Urol Clin North Am; 2008 Nov; 35(4):679-86; viii. PubMed ID: 18992621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive nephrectomy in metastatic clear-cell renal cell carcinoma: perspectives in the tyrosine kinase inhibitor era.
    Biswas S; Kelly J; Eisen T
    Oncologist; 2009 Jan; 14(1):52-9. PubMed ID: 19147692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma.
    Crispen PL; Blute ML
    Curr Urol Rep; 2012 Feb; 13(1):38-46. PubMed ID: 22105577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CANCER].
    Nosov AK; Novik AV; Vorobiev AV; Samartseva EE; Reva SA; Baldueva IA; Lushina PA
    Vopr Onkol; 2015; 61(3):494-8. PubMed ID: 26242167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is the cytoreductive nephrectomy still necessary in case of metastases?].
    Lebret T; Neuzillet Y; Pignot G
    Prog Urol; 2010 Mar; 20 Suppl 1():S33-7. PubMed ID: 20493441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving outcomes in patients with advanced renal cell carcinoma.
    Sosman JA
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):481-90. PubMed ID: 18366295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.